IL6 and pulmonary arterial hypertension: Serum studies of patients with PAH show increased levels of IL-6 compared with healthy patients, and even demonstrate IL-6 levels as a more accurate prognostic marker than traditional clinical tests (Selimovic et al., 2009; Soon et al., 2010).